Abstract
Aim: To determine the extent of unlicensed and off-label drugs prescribed in a neonatal unit at a University Hospital, Lyon, France. Methods: We conducted a prospective cohort study of newborns who were admitted to the neonatal unit in France during a 4 month-period (from January 1st to April 30th 2009). Using French primary reference source (Vidal 2009), all drug prescriptions were assessed to determine the extent of unlicensed or off-label use.
Results: A total of 65 newborns, 55 preterm and 10 full-terms were admitted to the neonatal ward and received 265 prescriptions. Fifty four percent (143/265) of prescribed drugs were licensed, 16.6% (44/265) were off-label for paediatric use, 21% (56/265) for age, 2.4% (6/265) for dosage and 6% (16/265) for route of administration. Unlicensed drug utilisation has not been detected. Seventy one percent (46/65) of infants received at least one offlabel prescription.
Conclusion: Prescriptions of off-label drugs in neonatal unit is common. Clinical trials assessing the benefit and harms of off-label or unlicensed drugs frequently prescribed should improve the lack of trial-based data for children.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nguyen, K., Claris, O. & Kassai, B. 472 Unlicensed and Off-Label Drug Use in a Neonatal Unit in France. Pediatr Res 68 (Suppl 1), 241–242 (2010). https://doi.org/10.1203/00006450-201011001-00472
Issue date:
DOI: https://doi.org/10.1203/00006450-201011001-00472
